LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

Aim. To analyze the relation of Lp(a) and atherosclerosis development in familial hypercholesterolemia (FHCE).Material and methods. Totally, 81 patient with definite FHCE studied, mean age 39,1±0,4 y. o. The participants were selected to two groups: first — with increased level of Lp(a) >0,3...

Full description

Bibliographic Details
Main Authors:	V. A. Korneva, T. Yu. Kuznetsova, G. P. Tikhova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2016-06-01
Series:	Российский кардиологический журнал
Subjects:	familial hypercholesterolemia lipoprotein (a) ischemic heart disease
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/510

Similar Items

Phenotype receptor gene mutations in low-density lipoprotein in patients with familial hypercholesterolemia in Karelia
by: V. A Korneva, et al.
Published: (2015-03-01)

Lipoprotein metabolism in familial hypercholesterolemia
by: Kévin Chemello, et al.
Published: (2021-01-01)

Role of lipoprotein apheresis in the management of familial hypercholesterolemia
by: Shamanna Seshadri Iyengar, et al.
Published: (2021-01-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
by: Amalia Despoina Koutsogianni, et al.
Published: (2022-11-01)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
by: Elena Olmastroni, et al.
Published: (2023-05-01)

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
by: Anthony Wang, et al.
Published: (2016-07-01)

ANALYSIS OF THE TRADITIONAL RISK FACTORS INFLUENCE ON DEVELOPMENT OF ISCHEMIC HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2017-06-01)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
by: Sayaka Funabashi, et al.
Published: (2022-08-01)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
by: Uliana V. Chubykina, et al.
Published: (2022-01-01)

Monozygotic twins with familial hypercholesterolemia and high lipoprotein(a) levels leading to identical cardiovascular outcomes: Case report and review of the literature
by: Meral Kayıkçıoğlu, et al.
Published: (2020-07-01)

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
by: Victoria Korneva, et al.
Published: (2022-01-01)

CLINICAL GUIDELINES FOR FAMILIAL HYPERCHOLESTEROLEMIA
by: M. V. Ezhov, et al.
Published: (2019-03-01)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
by: Wann Jia Loh, et al.
Published: (2022-04-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
by: V. B. Vasilyev, et al.
Published: (2022-06-01)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
by: Hayato Tada, et al.
Published: (2022-12-01)

Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients
by: J. Víšek, et al.
Published: (2021-02-01)

Low-density lipoprotein apheresis in a pediatric patient of familial hypercholesterolemia: Primi experientia from a tertiary care center in North India
by: Kanchan Dogra, et al.
Published: (2017-01-01)

Just not cosmesis! Role of low-density lipoprotein apheresis in familial hypercholesterolemia: Experience at a newly developed tertiary care institution in Northern India
by: Daljit Kaur, et al.
Published: (2021-01-01)

Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia
by: Uffe Ravnskov, et al.
Published: (2022-08-01)

Homozygous familial hypercholesterolemia
by: Ravi Kumar Parihar, et al.
Published: (2012-01-01)

New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia
by: V. S. Emelyanchik, et al.
Published: (2023-01-01)

Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
by: Melody Lok-Yi Chan, et al.
Published: (2022-06-01)

Prevalence of familial hypercholesterolemia and hyperlipoproteinemia(a) in patients with premature acute coronary syndrome
by: U. V. Chubykina, et al.
Published: (2022-07-01)

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
by: Eszter Berta, et al.
Published: (2022-06-01)

Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report
by: Cristiana Sequeira, et al.
Published: (2022-10-01)

The clinical manifestations of atherosclerosis in familial hypercholesterolemia
by: V A Korneva, et al.
Published: (2014-01-01)

Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning
by: Ákos Németh, et al.
Published: (2022-02-01)

Identifying Markers of Cardiovascular Event-Free Survival in Familial Hypercholesterolemia
by: Etienne Khoury, et al.
Published: (2020-12-01)

Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia
by: Vasilis Tsimihodimos, et al.
Published: (2002-02-01)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
by: Estíbaliz Jarauta, et al.
Published: (2020-12-01)

Gene transfer and genome editing for familial hypercholesterolemia
by: Cesare Canepari, et al.
Published: (2023-04-01)

Genetic Diagnostic Approaches in Familial Hypercholesterolemia Evaluation
by: Moldovan Valeriu, et al.
Published: (2021-07-01)

Familial Hypercholesterolemia
by: FENG Siqin, et al.
Published: (2023-01-01)

The panorama of familial hypercholesterolemia in Latin America: a systematic review[S]
by: Roopa Mehta, et al.
Published: (2016-12-01)

Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein
by: Ewa Wieczorek, et al.
Published: (2021-04-01)

Improved detection of familial hypercholesterolemia by determining low density lipoprotein receptor expression in mitogen-induced proliferating lymphocytes
by: Pak-cheung Chan, et al.
Published: (1998-11-01)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
by: Chin-Chou Huang, et al.
Published: (2020-07-01)

Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
by: Linda Omer, et al.
Published: (2020-04-01)

The burden of hypercholesterolemia and ischemic heart disease in an ageing world
by: Angela Pirillo, et al.
Published: (2023-07-01)